Can a smartphone app help prevent postpartum depression?
NCT ID NCT05518162
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested whether a smartphone app called InBloom could help prevent postpartum depression in pregnant people at risk. 152 participants were randomly assigned to use the app or attend a weekly group program called ROSE. The study measured depression rates and severity up to three months after giving birth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
InBloom app (digital therapeutic)
What this could lead to
If effective, the InBloom app could offer a convenient, scalable way to help prevent postpartum depression in at-risk women.
What could go wrong
This is a completed trial, but results are not yet widely reported. The app may not be as effective as in-person group sessions, and digital interventions can have low engagement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST PARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Rochester Medical Center
Rochester, New York, 14642, United States